Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

156
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
156
Actuarial Approach01:20

Actuarial Approach

110
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
110
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

247
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
247
Cancer Survival Analysis01:21

Cancer Survival Analysis

413
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
413
Relative Risk01:12

Relative Risk

274
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
274
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

111
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
111

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Optimizing an ultrasonic levitator with two confronting emitters to levitate wavelength-scaled disks.

The Journal of the Acoustical Society of America·2026
Same author

Hydroxyethyl Starch and Perioperative Complications: a Systematic Review and Meta-analysis.

Anesthesiology·2026
Same author

Outcomes Research Consortium: Thirty-five-year Anniversary.

Anesthesiology·2025
Same author

A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

By Way of Introduction ….

Anesthesiology·2025

Related Experiment Video

Updated: Aug 16, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Extended-age Out-of-sample Validation of Risk Stratification Index 3.0 Models Using Commercial All-payer Claims.

Scott Greenwald1, George F Chamoun1, Nassib G Chamoun1

  • 1Health Data Analytics Institute, Dedham, Massachusetts.

Anesthesiology
|December 20, 2022
PubMed
Summary

Risk Stratification Index 3.0 models accurately predict hospital outcomes in younger adults, similar to Medicare patients. These validated models can guide patient management across diverse adult populations.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K

Related Experiment Videos

Last Updated: Aug 16, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K

Area of Science:

  • Health Informatics
  • Predictive Analytics
  • Clinical Risk Stratification

Background:

  • Previous Risk Stratification Index 3.0 (RSI 3.0) models were developed for Medicare patients (≥65 years).
  • These models utilized International Classification of Diseases, Tenth Revision (ICD-10) trajectories and admission data.
  • The study aimed to assess RSI 3.0 model performance in younger, healthier populations.

Purpose of the Study:

  • To evaluate the predictive accuracy of existing RSI 3.0 models in younger and healthier patient cohorts.
  • To determine if RSI 3.0 models are generalizable beyond the elderly Medicare population.
  • To assess the models' ability to predict utilization and adverse events in diverse hospital admissions.

Main Methods:

  • Analysis of All Payer Claims data for medical and surgical hospital admissions in Utah and Oregon (2017).
  • Prospective application of pre-existing RSI 3.0 models to younger populations.
  • Comparison of model performance against previous validation in Medicare patients.

Main Results:

  • Model performance in Utah and Oregon populations was comparable or superior to Medicare validation.
  • Average area under the curve (AUC) was 0.83, with R2 values of 0.93 (Utah) and 0.85 (Oregon).
  • Mean sensitivity for the highest risk group ranged from 28% (Utah) to 37% (Oregon).

Conclusions:

  • Risk Stratification Index 3.0 models demonstrate robust predictive performance across diverse adult hospital admissions.
  • Administrative claims-based predictive modeling provides valuable individualized risk profiles at admission.
  • The findings support the broad validity and utility of RSI 3.0 models for guiding patient management.